CD105 expression in oral capillary hemangiomas and cavernous hemangiomas
Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are characterized by increased numbers of normal and abnormal blood vessels. However, the causes of these lesions are not well understood. CD105 (end...
Saved in:
Published in: | Journal of Oral Science Vol. 57; no. 1; pp. 45 - 53 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Japan
Nihon University School of Dentistry
01-03-2015
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are characterized by increased numbers of normal and abnormal blood vessels. However, the causes of these lesions are not well understood. CD105 (endoglin) is predominantly expressed in proliferating blood endothelial cells (ECs). We analyzed expressions of CD105, CD34, von Willebrand factor, Ki-67, cyclooxygenase-2 (COX-2), and vascular endothelial growth factor (VEGF)-A in 31 capillary hemangiomas and 34 cavernous hemangiomas. Staining scores were calculated as the product of the proportion score and intensity score. Morphologically normal oral mucosa specimens (n = 10) were simultaneously evaluated as normal controls. As compared with cavernous hemangiomas and normal controls, capillary hemangiomas had higher staining scores for CD105, VEGF-A, and COX-2. The Ki-67 labeling index was significantly higher in capillary hemangiomas than in cavernous hemangiomas and normal controls (P < 0.01). These findings suggest that the biological characteristics of capillary and cavernous hemangiomas are quite different. The ECs of capillary hemangiomas actively proliferated and were generally regulated by VEGF-A. In contrast, the ECs of cavernous hemangiomas lacked proliferative activity. These results suggest that angiogenesis and vasodilatation of pre-existing blood vessels are important in the development of capillary hemangioma and cavernous hemangioma, respectively. (J Oral Sci 57, 45-53, 2015) |
---|---|
AbstractList | Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are characterized by increased numbers of normal and abnormal blood vessels. However, the causes of these lesions are not well understood. CD105 (endoglin) is predominantly expressed in proliferating blood endothelial cells (ECs). We analyzed expressions of CD105, CD34, von Willebrand factor, Ki-67, cyclooxygenase-2 (COX-2), and vascular endothelial growth factor (VEGF)-A in 31 capillary hemangiomas and 34 cavernous hemangiomas. Staining scores were calculated as the product of the proportion score and intensity score. Morphologically normal oral mucosa specimens (n = 10) were simultaneously evaluated as normal controls. As compared with cavernous hemangiomas and normal controls, capillary hemangiomas had higher staining scores for CD105, VEGF-A, and COX-2. The Ki-67 labeling index was significantly higher in capillary hemangiomas than in cavernous hemangiomas and normal controls (P < 0.01). These findings suggest that the biological characteristics of capillary and cavernous hemangiomas are quite different. The ECs of capillary hemangiomas actively proliferated and were generally regulated by VEGF-A. In contrast, the ECs of cavernous hemangiomas lacked proliferative activity. These results suggest that angiogenesis and vasodilatation of pre-existing blood vessels are important in the development of capillary hemangioma and cavernous hemangioma, respectively. (J Oral Sci 57, 45-53, 2015) Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are characterized by increased numbers of normal and abnormal blood vessels. However, the causes of these lesions are not well understood. CD105 (endoglin) is predominantly expressed in proliferating blood endothelial cells (ECs). We analyzed expressions of CD105, CD34, von Willebrand factor, Ki-67, cyclooxygenase-2 (COX-2), and vascular endothelial growth factor (VEGF)-A in 31 capillary hemangiomas and 34 cavernous hemangiomas. Staining scores were calculated as the product of the proportion score and intensity score. Morphologically normal oral mucosa specimens (n = 10) were simultaneously evaluated as normal controls. As compared with cavernous hemangiomas and normal controls, capillary hemangiomas had higher staining scores for CD105, VEGF-A, and COX-2. The Ki-67 labeling index was significantly higher in capillary hemangiomas than in cavernous hemangiomas and normal controls (P < 0.01). These findings suggest that the biological characteristics of capillary and cavernous hemangiomas are quite different. The ECs of capillary hemangiomas actively proliferated and were generally regulated by VEGF-A. In contrast, the ECs of cavernous hemangiomas lacked proliferative activity. These results suggest that angiogenesis and vasodilatation of pre-existing blood vessels are important in the development of capillary hemangioma and cavernous hemangioma, respectively. Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are characterized by increased numbers of normal and abnormal blood vessels. However, the causes of these lesions are not well understood. CD105 (endoglin) is predominantly expressed in proliferating blood endothelial cells (ECs). We analyzed expressions of CD105, CD34, von Willebrand factor, Ki-67, cyclooxygenase-2 (COX-2), and vascular endothelial growth factor (VEGF)-A in 31 capillary hemangiomas and 34 cavernous hemangiomas. Staining scores were calculated as the product of the proportion score and intensity score. Morphologically normal oral mucosa specimens (n = 10) were simultaneously evaluated as normal controls. As compared with cavernous hemangiomas and normal controls, capillary hemangiomas had higher staining scores for CD105, VEGF-A, and COX-2. The Ki-67 labeling index was significantly higher in capillary hemangiomas than in cavernous hemangiomas and normal controls (P < 0.01). These findings suggest that the biological characteristics of capillary and cavernous hemangiomas are quite different. The ECs of capillary hemangiomas actively proliferated and were generally regulated by VEGF-A. In contrast, the ECs of cavernous hemangiomas lacked proliferative activity. These results suggest that angiogenesis and vasodilatation of pre-existing blood vessels are important in the development of capillary hemangioma and cavernous hemangioma, respectively. |
Author | Matsue, Yasuyoshi Matsumoto, Naoyuki Nomoto, Shouta Tsuchiya, Motomi Oki, Hidero Komiyama, Kazuo Takamura, Tsuyoshi Nishikawa, Yohichi |
Author_xml | – sequence: 1 fullname: Matsumoto, Naoyuki organization: Department of Pathology, Nihon University School of Dentistry – sequence: 2 fullname: Tsuchiya, Motomi organization: Department of Pathology, Nihon University School of Dentistry – sequence: 3 fullname: Nomoto, Shouta organization: Department of Oral and Maxillofacial Surgery, Nihon University School of Dentistry – sequence: 4 fullname: Matsue, Yasuyoshi organization: Department of Pathology, Nihon University School of Dentistry – sequence: 5 fullname: Nishikawa, Yohichi organization: Department of Pathology, Nihon University School of Dentistry – sequence: 6 fullname: Takamura, Tsuyoshi organization: Department of Oral and Maxillofacial Surgery, Nihon University School of Dentistry – sequence: 7 fullname: Oki, Hidero organization: Department of Oral and Maxillofacial Surgery, Nihon University School of Dentistry – sequence: 8 fullname: Komiyama, Kazuo organization: Department of Pathology, Nihon University School of Dentistry |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25807908$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkD1PwzAURS1URGlhZEUZWVLs2I6TDVQ-ilSJBWbLcV7aVIkd7ATBv8dVSlUvftI9OnrvztDEWAMI3RC8SChl9zvrzeDLBRcLxs_QJckyHLM8SSdhpoyGmbIpmnm_w5glqeAXaJrwDIscZ5dotXwimEfw0znwvrYmqk1knWoirbq6aZT7jbbQKrOpbat8pEwZkm9wxg7-NLlC55VqPFwf_jn6fHn-WK7i9fvr2_JxHWtO0z6uhMiLqiBFKRjkSVkQzXLGE8KrHJMqI5RoKAgLD0BjlikQQFWugLBSC07n6G70ds5-DeB72dZeQ9jUQFhJkjQVlKUiywIaj6h21nsHlexc3YaLJMFyX548lCe5kGyvvj2oh6KF8kj_txWAhxHY-V5t4Ago19e6gVMdGZ3HSG-Vk2DoHxkPhk0 |
CitedBy_id | crossref_primary_10_3390_dj10110214 crossref_primary_10_5005_jsd_6_2_40 crossref_primary_10_1016_j_jaad_2018_09_061 crossref_primary_10_3389_fmed_2023_1115212 crossref_primary_10_1007_s11282_021_00511_z crossref_primary_10_12998_wjcc_v10_i5_1617 |
Cites_doi | 10.4049/jimmunol.141.6.1925 10.1016/0888-7543(92)90310-O 10.2176/nmc.47.5 10.1111/j.1440-1827.2005.01843.x 10.1007/s00405-010-1472-z 10.1902/jop.2000.71.5.701 10.1038/nm0603-669 10.1016/j.tripleo.2008.08.011 10.1053/j.seminhematol.2004.09.006 10.1096/fj.01-1010fje 10.1016/j.cardiores.2005.09.019 10.1097/00000372-199408000-00001 10.1080/000155599750009834 10.1002/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.0.CO;2-X 10.1002/path.1711750109 10.1111/j.1600-0714.2010.00969.x 10.1007/BF02981972 10.1016/j.cardiores.2004.10.036 10.1067/moe.2002.124461 10.1002/(SICI)1096-9896(1998110)186:3<313::AID-PATH188>3.0.CO;2-X 10.1182/blood.V90.6.2300 10.1038/nature12207 10.1007/s00431-014-2403-6 10.1038/modpathol.2010.168 10.1016/0092-8674(95)90127-2 10.1073/pnas.0307640100 10.1093/ajcp/75.2.167 10.4049/jimmunol.134.2.1276 10.1371/journal.pone.0086273 |
ContentType | Journal Article |
Copyright | 2015 by Nihon University School of Dentistry |
Copyright_xml | – notice: 2015 by Nihon University School of Dentistry |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.2334/josnusd.57.45 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Dentistry |
EISSN | 1880-4926 |
EndPage | 53 |
ExternalDocumentID | 10_2334_josnusd_57_45 25807908 article_josnusd_57_1_57_45_article_char_en |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 29L 2WC 34H 3O- 53G 5GY 7.U AAWTL ABOCM ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK E3Z EBD EBS EJD F5P JSF JSH KQ8 M~E OK1 RJT RNS RZJ TKC TR2 WOW X7M CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c536t-f779bfb1bd74e92db1c4945215f901f8131ceb14444eec048ae7e3a9ae14dc753 |
ISSN | 1343-4934 |
IngestDate | Fri Apr 12 03:04:10 EDT 2024 Fri Aug 23 03:55:35 EDT 2024 Thu May 23 23:20:43 EDT 2024 Thu Aug 17 20:29:27 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c536t-f779bfb1bd74e92db1c4945215f901f8131ceb14444eec048ae7e3a9ae14dc753 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/josnusd/57/1/57_45/_article/-char/en |
PMID | 25807908 |
PQID | 1667346788 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1667346788 crossref_primary_10_2334_josnusd_57_45 pubmed_primary_25807908 jstage_primary_article_josnusd_57_1_57_45_article_char_en |
PublicationCentury | 2000 |
PublicationDate | 2015-03-01 |
PublicationDateYYYYMMDD | 2015-03-01 |
PublicationDate_xml | – month: 03 year: 2015 text: 2015-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Journal of Oral Science |
PublicationTitleAlternate | J Oral Sci |
PublicationYear | 2015 |
Publisher | Nihon University School of Dentistry |
Publisher_xml | – name: Nihon University School of Dentistry |
References | 9. Gougos A, Letarte M (1988) Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol 15, 1925-1933. 32. Wu G, Luo J, Rana JS, Laham R, Sellke FW, Li J (2006) Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res 69, 512-519. 14. Tsujii M, DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493-501. 26. Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M et al. (2013) EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498, 492-496. 20. Wilting J, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Borges J et al. (2002) The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 16, 1271-1273. 19. Bragado R, Bello E, Requena L, Renedo G, Texeiro E, Alvarez MV et al. (1999) Increased expression of vascular endothelial growth factor in pyogenic granulomas. Acta Derm Venereol 79, 422-425. 5. Satterthwaite AB, Burn TC, Le Beau MM, Tenen DG (1992) Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. Genomics 12, 788-794. 7. Mendolicchio GL, Ruggeri ZM (2005) New perspectives on von Willebrand factor functions in hemostasis and thrombosis. Semin Hematol 42, 5-14. 13. Janmohamed SR, Madern GC, de Laat PC, Oranje AP (2015) Educational paper: pathogenesis of infantile haemangioma, an update 2014 (part I). Eur J Pediatr 174, 97-103. 16. Wakulich C, Jackson-Boeters L, Daley TD, Wysocki GP (2002) Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93, 573-579. 15. Wang D, DuBois RN (2004) Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch. Proc Natl Acad Sci U S A 101, 415-416. 21. Epivatianos A, Antoniades D, Zaraboukas T, Zairi E, Poulopoulos A, Kiziridou A et al. (2005) Pyogenic granuloma of the oral cavity: comparative study of its clinicopathological and immunohistochemical features. Pathol Int 55, 391-397. 10. Lebrin F, Deckers M, Bertolino P, Ten Dijke P (2005) TGF-β receptor function in the endothelium. Cardiovasc Res 65, 599-608. 23. Wood HB, May G, Healy L, Enver T, Morriss-Kay GM (1997) CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. Blood 90, 2300-2311. 25. Vassilopoulos SI, Tosios KI, Panis VG, Vrotsos JA (2011) Endothelial cells of oral pyogenic granulomas express eNOS and CD105/endoglin: an immunohistochemical study. J Oral Pathol Med 40, 345-351. 29. Nagasaka M, Naganuma H, Satoh E (2007) Growth potential of orbital cavernous hemangioma suggested by vascular endothelial growth factor and its receptor flk-1. Neurol Med Chir (Tokyo) 47, 5-10. 8. Quackenbush EJ, Letarte M (1985) Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies. J Immunol 134, 1276-1285. 24. Soares AB, Altemani A, Furuse C, Demasi AP, Gati C, Nunes N et al. (2008) Intravascular papillary endothelial hyperplasia: report of 2 cases and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106, 708-711. 3. Sangueza OP, Kasper RC, LeBoit P, Calonje E, Lee KC, Chan JKC et al. (2006) Vascular tumours. In: World Health Organization classification of tumours. Pathology and genetics of skin tumours. LeBoit PE et al. ed, IARC press, Lyon, 233-246. 12. Turley H, Scott PA, Watts VM, Bicknell R, Harris AL, Gatter KC (1998) Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. J Pathol 186, 313-318. 1. Goldblum JR, Folpe AL, Weiss SW (2013) Enzinger and Weiss’s Soft tissue tumors. 6th ed, Elsevier, Philadelphia, 639-680. 27. Liu Z, Lebrin F, Maring JA, van den Driesche S, van der Brink, van Dinther M S et al. (2014) ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis. PLoS One 28, e86273. 31. Yuan K, Jin YT, Lin MT (2000) The detection and comparison of angiogenesis-associated factors in pyogenic granuloma by immunohistochemistry. J Periodontol 71, 701-709. 6. Denis CV (2002) Molecular and cellular biology of von Willebrand factor. Int J Hematol 75, 3-8. 18. Martìn-Padura I, De Castellarnau C, Uccini S, Pilozzi E, Natali PG, Nicotra MR et al. (1995) Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas. J Pathol 175, 51-57. 28. Burgdorf WH, Mukai K, Rosai J (1981) Immunohistochemical identification of factor VIII-related antigen in endothelial cells of cutaneous lesions of alleged vascular nature. Am J Clin Pathol 75, 167-171. 30. Miller DW, Graulich W, Karges B, Stahl S, Ernst M, Ramaswamy A et al. (1999) Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer 81, 568-572. 4. Chiu A, Czader M, Cheng L, Hasserjian RP, Wang M, Bhagavathi S et al. (2011) Clonal X-chromosome inactivation suggests that splenic cord capillary hemangioma is a true neoplasm and not a subtype of splenic hamartoma. Mod Pathol 24, 108-116. 2. International Society for the Study of Vascular Anomalies (2014) ISSVA classification for vascular anomalies. Approved at the 20th ISSVA Workshop, Melbourne. 22. Vasconcelos MG, Alves PM, Vasconcelos RG, da Silveira ÉJ, Medeiros AM, de Queiroz LM (2011) Expression of CD34 and CD105 as markers for angiogenesis in oral vascular malformations and pyogenic granulomas. Eur Arch Otorhinolaryngol 268, 1213-1217. 11. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9, 669-676. 17. Suster S, Wong TY (1994) On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations. Am J Dermatopathol 16, 355-363. 22 23 24 25 26 27 28 29 30 31 10 32 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 |
References_xml | – ident: 2 – ident: 9 doi: 10.4049/jimmunol.141.6.1925 – ident: 5 doi: 10.1016/0888-7543(92)90310-O – ident: 29 doi: 10.2176/nmc.47.5 – ident: 21 doi: 10.1111/j.1440-1827.2005.01843.x – ident: 22 doi: 10.1007/s00405-010-1472-z – ident: 31 doi: 10.1902/jop.2000.71.5.701 – ident: 11 doi: 10.1038/nm0603-669 – ident: 24 doi: 10.1016/j.tripleo.2008.08.011 – ident: 7 doi: 10.1053/j.seminhematol.2004.09.006 – ident: 20 doi: 10.1096/fj.01-1010fje – ident: 32 doi: 10.1016/j.cardiores.2005.09.019 – ident: 17 doi: 10.1097/00000372-199408000-00001 – ident: 19 doi: 10.1080/000155599750009834 – ident: 30 doi: 10.1002/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.0.CO;2-X – ident: 18 doi: 10.1002/path.1711750109 – ident: 25 doi: 10.1111/j.1600-0714.2010.00969.x – ident: 6 doi: 10.1007/BF02981972 – ident: 3 – ident: 10 doi: 10.1016/j.cardiores.2004.10.036 – ident: 16 doi: 10.1067/moe.2002.124461 – ident: 12 doi: 10.1002/(SICI)1096-9896(1998110)186:3<313::AID-PATH188>3.0.CO;2-X – ident: 23 doi: 10.1182/blood.V90.6.2300 – ident: 26 doi: 10.1038/nature12207 – ident: 1 – ident: 13 doi: 10.1007/s00431-014-2403-6 – ident: 4 doi: 10.1038/modpathol.2010.168 – ident: 14 doi: 10.1016/0092-8674(95)90127-2 – ident: 15 doi: 10.1073/pnas.0307640100 – ident: 28 doi: 10.1093/ajcp/75.2.167 – ident: 8 doi: 10.4049/jimmunol.134.2.1276 – ident: 27 doi: 10.1371/journal.pone.0086273 |
SSID | ssj0042675 |
Score | 2.1092968 |
Snippet | Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are... |
SourceID | proquest crossref pubmed jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 45 |
SubjectTerms | Adolescent Adult Aged Aged, 80 and over angiogenesis Antigens, CD34 - metabolism capillary hemangioma cavernous hemangioma CD105 Child Cyclooxygenase 2 - metabolism Dentistry Endoglin - metabolism Female Hemangioma, Capillary - metabolism Hemangioma, Cavernous - metabolism Humans Immunoenzyme Techniques immunohistochemistry Ki-67 Antigen - metabolism Male Middle Aged Mouth Neoplasms - metabolism Vascular Endothelial Growth Factor A - metabolism von Willebrand Factor - metabolism |
Title | CD105 expression in oral capillary hemangiomas and cavernous hemangiomas |
URI | https://www.jstage.jst.go.jp/article/josnusd/57/1/57_45/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/25807908 https://search.proquest.com/docview/1667346788 |
Volume | 57 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Oral Science, 2015, Vol.57(1), pp.45-53 |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfYQIIXxOcosClIiBeUUid2bT-itdMQozysk8ZT5DjOVhDJtDQP_e-5s_PVSZPGw_oQVf44qfe73J2v5ztCPmaZVHLKTSi5nIYsEpNQU52GxvDUgv0DIXGhi1OxOJezOZv3Sez92L0iDWOANd6c_Q-0O6IwAN8Bc3gC6vC8E-6HM_BlsHC_T3B1iYzuFr7RV9hh6HrzGeu0FhcrzAzy19o09tvFXNjBzC1eqyPVmM0-mr2GX1i6hkygrstN_WfVRQQq7LaycS7qD1jyt5tZlO2W08uyXustai7M-ktX9aasLlfD0ATlfW7W2Hp1CtohxJKEQ33rC1JvyZVXnr6uZGOGfQnhmwo-imOGCr6sirrKxlyM203DQtqLn8nR2clJspyfL3fIwwh0kDttf_veGmnwSwT3JVeR5JctglsuyqPf4KVf2NsPIM4RWT4jTxssgq8e-ufkgS1ekMczzPrCxn0vybETgaAXgWBVBIhb0IlAMAA6ABEIOhEYzrwiZ0fz5eFx2DTMCA2Pp-swF0KleUrTTDCroiylhikGDhrPwe3LJY2pAdvM4GOtAd2trbAx1menLDNwcH1NdouysG9IkEdTMMkTKrXImFFUi5zpTKXMpEYrrkfkU8uj5MrXRUngPInMTBpmJlwkjI-I8hzsljWvxnAZ9Wu7KbxxCC_ziHxomZ6A1sO_snRhgRcJxW61YOOlHJE9j0ZHP-JyItREvr3D7nfkSS-478nu-rq2-2SnyuoDJy__AKRdiNQ |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CD105+expression+in+oral+capillary+hemangiomas+and+cavernous+hemangiomas&rft.jtitle=Journal+of+oral+science&rft.au=Matsumoto%2C+Naoyuki&rft.au=Tsuchiya%2C+Motomi&rft.au=Nomoto%2C+Shouta&rft.au=Matsue%2C+Yasuyoshi&rft.date=2015-03-01&rft.eissn=1880-4926&rft.volume=57&rft.issue=1&rft.spage=45&rft.epage=53&rft_id=info:doi/10.2334%2Fjosnusd.57.45&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1343-4934&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1343-4934&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1343-4934&client=summon |